Serum antibody against NY-ESO-1 and XAGE1 predicts clinical responses to anti-PD-1 therapy in non-small-cell lung cancer.

Serum antibody against NY-ESO-1 and XAGE1 predicts clinical responses to anti-PD-1 therapy in non-small-cell lung cancer.
复制标题

针对 NY-ESO-1 和 XAGE1 的血清抗体可预测非小细胞肺癌抗 PD-1 治疗的临床反应。

DOI:
--
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Oka M.
Oka M.
中科院分区:
--
文献类型:
--
作者:
Kurose K;Ohue Y;Karasaki T;Futami J;Irei I;Masuda T;Fukuda Ma;Kinoshita A;Matsushita H;Shimizu K;Yamaguchi H;Fukuda Mi;Kakimi K;Oka M.

文献摘要

相似文献